2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with HIV in 2 studies
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gulakowski, RJ | 1 |
| McMahon, JB | 1 |
| Staley, PG | 1 |
| Moran, RA | 1 |
| Boyd, MR | 1 |
| McMahon, J | 1 |
| Schmid, S | 1 |
| Weislow, O | 1 |
| Stinson, S | 1 |
| Camalier, R | 1 |
| Gulakowski, R | 1 |
| Shoemaker, R | 1 |
| Kiser, R | 1 |
| Dykes, D | 1 |
| Harrison, S | 1 |
2 other studies available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and HIV
| Article | Year |
|---|---|
A semiautomated multiparameter approach for anti-HIV drug screening.
Topics: Antiviral Agents; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fluoresceins; HIV; HIV | 1991 |
Feasibility of cellular microencapsulation technology for evaluation of anti-human immunodeficiency virus drugs in vivo.
Topics: Animals; Antibody Formation; Cells, Cultured; Drug Compounding; Drug Evaluation, Preclinical; Evalua | 1990 |